Anson Funds Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Anson Funds Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-122,650	Closed	-$4.83M	–	194
2023 Q2	$4.83M	Buy	+122,650	New	+$4.33M	0.8%	26

Anson Funds Management's ISEE Position: Q3 2023 in Review

Anson Funds Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 122,650 shares — an estimated $4.83M sold.

Anson Funds Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $4.83M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Anson Funds Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Anson Funds Management sold 122,650 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.83M.
Anson Funds Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Anson Funds Management's IVERIC bio, Inc. Common Stock position peaked at $4.83M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Anson Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.